Droplet digital polymerase chain reaction offers an improvisation over conventional immunohistochemistry and fluorescent in situ hybridization for ascertaining Her2 status of breast cancer

BACKGROUND: Droplet digital polymerase chain reaction (DDPCR) is a recent modality for detecting Her2 expression which is quantitative, cheaper, easier to standardize, and free from interobserver variation. PURPOSE: The purpose of this study is to incorporate DDPCR in the current diagnostic paradigm...

Descripción completa

Detalles Bibliográficos
Autores principales: Suryavanshi, Moushumi, Jaipuria, Jiten, Mehta, Anurag, Kumar, Dushyant, Panigrahi, Manoj Kumar, Verma, Haristuti, Saifi, Mumtaz, Sharma, Sanjeev, Tandon, Simran, Doval, Dinesh Chandra, Das, Bhudev C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
ORIGINAL ARTICLE: Breast Cancers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852626/
https://www.ncbi.nlm.nih.gov/pubmed/31807475
http://dx.doi.org/10.4103/sajc.sajc_344_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852626/
https://www.ncbi.nlm.nih.gov/pubmed/31807475
http://dx.doi.org/10.4103/sajc.sajc_344_18

Ejemplares similares